A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
Parents of 1000 healthy infants and toddlers living in Thailand were enrolled via digital recruitment, e-consent and screening. Participants completed questionnaires to assess the prevalence and management of FGIDs, impact on QoL, and efficacy of treatments.
• Recruitment was completed in under a month.
• Required survey responses were collected in 44 days.
• 127,431 data points were evaluated in real-time.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
Parents of 1000 healthy infants and toddlers living in Thailand were enrolled via digital recruitment, e-consent and screening. Participants completed questionnaires to assess the prevalence and management of FGIDs, impact on QoL, and efficacy of treatments.
• Recruitment was completed in under a month.
• Required survey responses were collected in 44 days.
• 127,431 data points were evaluated in real-time.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
Parents of 1000 healthy infants and toddlers living in Thailand were enrolled via digital recruitment, e-consent and screening. Participants completed questionnaires to assess the prevalence and management of FGIDs, impact on QoL, and efficacy of treatments.
• Recruitment was completed in under a month.
• Required survey responses were collected in 44 days.
• 127,431 data points were evaluated in real-time.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
Parents of 1000 healthy infants and toddlers living in Thailand were enrolled via digital recruitment, e-consent and screening. Participants completed questionnaires to assess the prevalence and management of FGIDs, impact on QoL, and efficacy of treatments.
• Recruitment was completed in under a month.
• Required survey responses were collected in 44 days.
• 127,431 data points were evaluated in real-time.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
Parents of 1000 healthy infants and toddlers living in Thailand were enrolled via digital recruitment, e-consent and screening. Participants completed questionnaires to assess the prevalence and management of FGIDs, impact on QoL, and efficacy of treatments.
• Recruitment was completed in under a month.
• Required survey responses were collected in 44 days.
• 127,431 data points were evaluated in real-time.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
Parents of 1000 healthy infants and toddlers living in Thailand were enrolled via digital recruitment, e-consent and screening. Participants completed questionnaires to assess the prevalence and management of FGIDs, impact on QoL, and efficacy of treatments.
• Recruitment was completed in under a month.
• Required survey responses were collected in 44 days.
• 127,431 data points were evaluated in real-time.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
Parents of 1000 healthy infants and toddlers living in Thailand were enrolled via digital recruitment, e-consent and screening. Participants completed questionnaires to assess the prevalence and management of FGIDs, impact on QoL, and efficacy of treatments.
• Recruitment was completed in under a month.
• Required survey responses were collected in 44 days.
• 127,431 data points were evaluated in real-time.
ObvioHealth successfully conducted a clinical trial for RedHill Biopharma to test the safety and efficacy of an oral medication for the treatment of COVID-19 symptoms. We designed this decentralized study to be conducted where the majority of patients recover from illness—in their homes. When the trial was launched in 2021, its unique combination of home health visits, electronic patient-reported outcomes (ePRO), and remote monitoring devices was pioneering—COVID-19 studies were typically conducted inside hospitals.
ObvioHealth and Renovia conducted a groundbreaking study on the efficacy of an at-home medical device for the treatment of stress and mixed urinary incontinence. Read more below to understand how we delivered a successful, fully virtual clinical trial in the midst of the pandemic.